Kataoka, Josefin
Larsson, Ingrid
Lindgren, Eva
Kindstrand, Li Oskarson
Schmidt, Johanna
Stener-Victorin, Elisabet
Funding for this research was provided by:
Vetenskapsrådet (2018-02435)
• Distinguished Investigator Grant – Endocrinology and Metabolism, Novo Nordisk Foundation (NNF22OC0072904)
Diabetes Foundation: (DIA2021-633)
Novo Nordisk Fonden (NNF18OC0033992 and NNF19OC0056647)
Swedish federal government under the LUA/ALF agreement (ALFGBG-429501)
Karolinska Institute
Article History
Received: 27 August 2022
Revised: 25 September 2022
Accepted: 5 October 2022
First Online: 29 October 2022
Declarations
:
: The study was approved by the Regional Ethical Review Board of the University of Gothenburg (diary number 106 − 11), followed the Helsinki Declaration of 1975, as revised in 2008, and is registered at the Clinical trial.gov: NCT01319162. All participants received written and oral information and signed informed consent before any examination.
: Data regarding any of the subjects in the study has not been previously published unless specified. Data will be made available to the editors of the journal for review or query upon request.
: The authors have no conflict or competing interests to disclose.